Stroke prevention in atrial fibrillation trial.
نویسنده
چکیده
T he increasing recognition of the high risk of embolic stroke and other systemic emboli in patients with nonrheumatic atrial fibrilla-tion, the widespread experience with lower-intensity warfarin regimens, and the extensive evidence for the efficacy of aspirin in a variety of vascular diseases led to the conduction of seven large trials of warfarin, four of which also included an evaluation of aspirin. Three of these trials have been published,1-4 and a fourth is in press.5 The Stroke Prevention in Atrial Fibrillation (SPAF) trial6 is reported in this issue of Circulation, and comment on the results is timely. The SPAF investigators evaluated both warfarin and aspirin among patients with nonrheumatic atrial fibrillation. The study examined two groups of patients defined on the basis of their eligibility for warfarin therapy. The 627 patients in group 1 were judged by their physicians to be eligible for warfarin therapy and were randomized equally to open-label warfarin (prothrombin time, 1.3-1.8xcontrol; INR, 2.8-4.5) or double-blind to aspirin (enteric coated, 325 mg daily) or matching placebo. The 703 patients in group 2 were considered ineligible for warfarin therapy and were randomly allocated in double-blind fashion to aspirin (enteric coated, 325 mg daily) or matching placebo.
منابع مشابه
Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III trial.
BACKGROUND AND PURPOSE Transient ischemic attacks (TIAs) are infrequent in patients with atrial fibrillation, and little is known about the long-term prognosis and response to antithrombotic therapy. METHODS This study was a pooled analysis of participants in 2 randomized trials, the European Atrial Fibrillation Trial and the Stroke Prevention in Atrial Fibrillation III Trial, comparing those...
متن کاملAntithrombotic therapy in atrial fibrillation.
Abbreviations: ACUTE 5 Assessment of Cardioversion Using Transesophageal Echocardiography; AF 5 atrial fibrillation; AFASAK 5 Atrial Fibrillation Aspirin and Anticoagulation; AFI 5 Atrial Fibrillation Investigators; BAATAF 5 Boston Area Anticoagulation Trial for Atrial Fibrillation; CAFA 5 Canadian Atrial Fibrillation Anticoagulation; CI 5 confidence interval; DC 5 direct current; EAFT 5 Europe...
متن کاملStroke prevention in atrial fibrillation: Commentary regarding the AAN's evidence-based guideline update.
Atrial fibrillation is a common, potentially preventable cause of disabling stroke in the elderly, particularly in elderly women, resulting from embolism of stasis-precipitated thrombi formed in the left atrial appendage. In 1989, the first randomized clinical trial of anticoagulant therapy in atrial fibrillation showed that warfarin produced a large reduction in ischemic stroke.1 In the ensuin...
متن کاملSecondary stroke prevention in atrial fibrillation: lessons from clinical practice.
BACKGROUND AND PURPOSE Secondary prevention trials do not distinguish outcomes according to stroke cause. The purpose of the study was to determine whether trial efficacy of anticoagulation for secondary prevention could be replicated in clinical practice in strokes of different etiology. METHODS A 2-year observation study was undertaken in 288 stroke patients with atrial fibrillation (mean a...
متن کاملRisk of Ischemic Stroke and Stroke Prevention in Patients with Atrial Fibrillation and Renal Dysfunction.
Chronic kidney disease (CKD) has been identified as an important risk factor for new-onset atrial fibrillation (AF) and would significantly increase the risk of AF-related strokes. Stroke prevention in AF patients with CKD is a big challenge, especially for patients with end-stage renal disease (ESRD) undergoing long-term dialysis. In addition to an increase risk of stroke, renal dysfunction wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Circulation
دوره 84 2 شماره
صفحات -
تاریخ انتشار 1991